{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-019783","form_type":"8-K","ticker":"BAX","cik":"0000010456","company_name":"BAXTER INTERNATIONAL INC","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.020333+00:00","generated_at":"2026-06-02T23:47:14.273393+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Baxter Q1 2024: sales $3.59B (+3% CC), adj. EPS $0.65, beating guidance; FY2024 adj. EPS guidance $2.88-$2.98","bullets":["Q1 sales $3.59B (+2% reported, +3% CC); GAAP EPS $0.07; adj. EPS $0.65, above guidance.","FY 2024 guidance: sales growth ~2% reported, 2-3% CC; adj. EPS $2.88-$2.98.","FDA clearance for Novum IQ large volume infusion pump and Dose IQ Safety Software.","CEO cited solid operational execution and benefits from new operating model."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-019783","json":"https://secwatch.observer/filing/0001628280-24-019783.json","markdown":"https://secwatch.observer/filing/0001628280-24-019783.md","text":"https://secwatch.observer/filing/0001628280-24-019783.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/10456/000162828024019783/0001628280-24-019783-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10456/000162828024019783/bax-20240502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T23:47:14.273393+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"18c5df91dca3b9bd6afd25284d618178fce2b8c2","claim":"BAXTER INTERNATIONAL INC updated its first quarter 2024 guidance (raised).","evidence_excerpt":"On May 2, 2024, Baxter International Inc. (the Company) issued an earnings press release for the period ended March 31, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/10456/000162828024019783/0001628280-24-019783-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2024"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}